Abstract:Phenotypic drug discovery (PDD) screens compounds in cellular models that represent disease-relevant phenotypes, offering a compelling alternative to traditional target-based approaches. Unlike conventional methods, where compounds act on a single predefined target, PDD identifies compounds capable of exerting therapeutic effects through multiple targets and mechanisms. This makes PDD particularly valuable for discovering first-in-class drugs, especially for diseases with poorly understood molecular mechanisms or those lacking validated therapeutic targets. By enabling broader exploration of biological systems and uncovering multi-target drugs (polypharmacology), PDD provides a powerful strategy for tackling complex diseases. In this study, we introduce PhenoScreen, a deep learning framework designed to advance PDD by utilizing large-scale compound-phenotype association data. Through contrastive learning, PhenoScreen connects chemical space with cellular morphological profiles, allowing for accurate prediction of compound-induced phenotypic changes. PhenoScreen can also accurately identfiy lead compounds which could induce user defined phenotypic shift but more novel scaffolds using different levels of phenotypic information reflected by diverse compounds. The model was validated across multiple screening tasks and successfully predicted active compounds inducing user-specified phenotypes with varying inhibitory effects in the osteosarcoma phenotypic model. Further, other than showing effectiveness to osteosarcoma, our experiments also showed that PhenoScreen demonstrated strong generalization to rhabdomyosarcoma, and the active compound we screened had an IC50 of up to 6.62 uM, suggesting its ability to capture key phenotypic features shared across cancer cells. These results underscore PhenoScreen's potential to accelerate drug discovery by identifying novel therapeutic pathways and increasing the diversity of viable drug candidates. PhenoScreen is accessible online via our group's web server for compound virtual screening at https://bailab.siais.shanghaitech.edu.cn/services/PhenoScreen/, and the source codes are available at https://github.com/Shihang-Wang-58/PhenoScreen.

Scalable, compressed phenotypic screening using pooled perturbations

Multiplexed, Image-Based Pooled Screens in Primary Cells and Tissues with PerturbView

Enhancing the Small-Scale Screenable Biological Space beyond Known Chemogenomics Libraries with Gray Chemical Matter─Compounds with Novel Mechanisms from High-Throughput Screening Profiles

A Fully Automated High-Throughput Flow Cytometry Screening System Enabling Phenotypic Drug Discovery

Predicting Cellular Responses to Complex Perturbations in High-Throughput Screens.

PhenoScreen: A Dual-Space Contrastive Learning Framework-based Phenotypic Screening Method by Linking Chemical Perturbations to Cellular Morphology

Genetic and Pharmacological Interrogation of Cancer Vulnerability Using a Multiplexed Cell Line Screening Platform

Learning interpretable cellular responses to complex perturbations in high-throughput screens

NanoStore: A Concept for Logistical Improvements of Compound Handling in High-Throughput Screening

Systematic reconstruction of molecular pathway signatures using scalable single-cell perturbation screens

Ultrahigh-Throughput Enzyme Engineering and Discovery in In Vitro Compartments

Image-Based Annotation of Chemogenomic Libraries for Phenotypic Screening

Image based annotation of Chemogenomic Libraries for Phenotypic Screening

Deducing the mechanism of action of compounds identified in phenotypic screens by integrating their multiparametric profiles with a reference genetic screen

Development of an automated 3D high content cell screening platform for organoid phenotyping

High-throughput mechanistic screening of non-equilibrium inhibitors by a fully automated data analysis pipeline in early drug-discovery

CRISPRmap: Sequencing-free optical pooled screens mapping multi-omic phenotypes in cells and tissue

Cost-Efficient Transcriptomic-Based Drug Screening

High-content imaging-based pooled CRISPR screens in mammalian cells

Multiplexed and reproducible high content screening of live and fixed cells using Dye Drop

High-throughput, microscopy-based screening and quantification of genetic elements